EDITORIAL
Published on 09 Aug 2022
Editorial: Advancements in immunology and immunotherapy for breast cancer
doi 10.3389/fonc.2022.979806
- 1,411 views
- 1 citation
- Frontiers in Oncology
- Breast Cancer
- Research Topics
- Advancements in Immunology and Immunotherapy for Breast Cancer
Advancements in Immunology and Immunotherapy for Breast Cancer
21k
Total downloads
91k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 08 Jun 2022
Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer
doi 10.3389/fonc.2022.820696
- 2,758 views
- 15 citations
ORIGINAL RESEARCH
Published on 21 Mar 2022
A Comprehensive Survey of Genomic Mutations in Breast Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets
doi 10.3389/fonc.2022.786438
- 3,151 views
- 11 citations
REVIEW
Published on 15 Mar 2022
Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
doi 10.3389/fonc.2022.802579
- 25,711 views
- 11 citations
ORIGINAL RESEARCH
Published on 14 Feb 2022
Effect of Early-Stage Human Breast Carcinoma on Monocyte Programming
doi 10.3389/fonc.2021.800235
- 5,874 views
- 26 citations
MINI REVIEW
Published on 28 Jan 2022
Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
doi 10.3389/fonc.2021.815772
- 5,387 views
- 25 citations
ORIGINAL RESEARCH
Published on 27 Jan 2022
A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer
doi 10.3389/fonc.2021.759952
- 3,546 views
- 9 citations
ORIGINAL RESEARCH
Published on 19 Jan 2022
Multi-Omics Analyses Revealed GOLT1B as a Potential Prognostic Gene in Breast Cancer Probably Regulating the Immune Microenvironment
doi 10.3389/fonc.2021.805273
- 2,240 views
- 4 citations
REVIEW
Published on 17 Jan 2022
Prospects of Immunotherapy for Triple-Negative Breast Cancer
doi 10.3389/fonc.2021.797092
- 8,101 views
- 26 citations
REVIEW
Published on 06 Jan 2022
Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy
doi 10.3389/fonc.2021.724424
- 7,742 views
- 18 citations
ORIGINAL RESEARCH
Published on 05 Jan 2022
The Therapeutic Effectiveness of Neoadjuvant Trastuzumab Plus Chemotherapy for HER2-Positive Breast Cancer Can Be Predicted by Tumor-Infiltrating Lymphocytes and PD-L1 Expression
doi 10.3389/fonc.2021.706606
- 2,210 views
- 11 citations
SYSTEMATIC REVIEW
Published on 16 Dec 2021
Immune Checkpoint Inhibitors Combined With Chemotherapy Compared With Chemotherapy Alone for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
doi 10.3389/fonc.2021.795650
- 2,640 views
- 9 citations
Published in
Frontiers in Oncology
- Breast Cancer
Impact
- 91kTopic views
- 69kArticle views
- 21kArticle downloads